NEW YORK (GenomeWeb) – Pressure Biosciences said today that is has completed the fourth closing of its $5 million private placement.

With the closing the company raised an additional $730,000, bring the total amount raised in the offering to nearly $4.8 million. It will issue senior secured debentures with a fixed conversion price of $.28 per restricted common share and common stock purchase warrants exercisable into a total of 1,303,571 shares of restricted stock at an exercise price of $.40 per share.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.